EUVIMEDEUVIMED entdecken
Crossref

Cutoff value of thyroglobulin in needle aspirates for screening neck masses of thyroid carcinoma

Koji Sakamoto iD, Hiroyuki Ozawa iD, Yoichiro Sato iD, Masashi Nakaishi, Atsuko Sakanushi iD, Takeshi Matsunobu iD, Kimihiro Okubo iD, Seiichi Shinden iD

Endocrine-Related Cancer · 2024

DOI: 10.1530/erc-24-0067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2024. Verfasst von Koji Sakamoto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Saiseikai Utsunomiya Hospital, Utsunomiya City, Tochigi, Japan. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroglobulin. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Measurement of thyroglobulin in fine-needle aspirates (FNA-Tg) is useful for the diagnosis of lymph node metastasis in thyroid carcinoma; however, the cutoff value remains unclear, particularly for the differential diagnosis of neck masses. To evaluate the cutoff value of FNA-Tg, we conducted a retrospective study of patients with neck masses outside the thyroid who pre-operatively underwent both FNAC and FNA-Tg, followed by pathological examination at our hospital from October 2015 to September 2020. The cutoff value of FNA-Tg was calculated using the receiver operating characteristic curve. Among 210 lesions, 57 were of thyroid origin and 153 lesions were not of thyroid origin. A high FNA-Tg value was observed in the lesions of thyroid origin ( P : 0.001), and the cutoff value at the minimum point of 100% specificity was 32.2 ng/mL with a sensitivity of 87.7%. Regarding the effect of serum anti-Tg antibodies, FNA-Tg values were significantly lower or not significantly different depending on the grouping, warranting further studies. Among the cases with papillary thyroid carcinoma, the sensitivity of FNAC and FNA-Tg was 71.4% and 87.5%, respectively. The cutoff value of FNA-Tg for the differential diagnosis of neck masses was higher compared to previous reports because some metastatic lymph nodes of carcinomas and lesions, other than lymph nodes, exhibited higher FNA-Tg values. Therefore, if FNA-Tg is to be used as a screening test for the differential diagnosis of neck masses in patients without proven thyroid carcinoma, it is necessary to establish a higher cutoff value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroglobulinHumansFemaleMaleBiopsy, Fine-NeedleMiddle AgedRetrospective StudiesAdultAgedLymphatic MetastasisThyroid Cancer, PapillaryYoung Adult

Stichwörter der Autor:innen

cutoff valuedifferential diagnosis of neck masseslesions other than the lymph nodesthyroglobulin in fine-needle aspirates

Substanzen

Thyroglobulin

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Saiseikai Utsunomiya Hospital, Utsunomiya City, Tochigi, Japan.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Nippon Medical School, Bunkyo-ku, Tokyo, Japan.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Keio University, Shinjuku-ku, Tokyo, Japan.

ORCID-Profile: Koji Sakamoto, Hiroyuki Ozawa, Yoichiro Sato, Atsuko Sakanushi, Takeshi Matsunobu, Kimihiro Okubo, Seiichi Shinden

Zitieren

APA

Sakamoto, K., Ozawa, H., Sato, Y., Nakaishi, M., Sakanushi, A., Matsunobu, T., Okubo, K., & Shinden, S. (2024). Cutoff value of thyroglobulin in needle aspirates for screening neck masses of thyroid carcinoma. Endocrine-Related Cancer. https://doi.org/10.1530/erc-24-0067

Vancouver

Sakamoto K, Ozawa H, Sato Y, Nakaishi M, Sakanushi A, Matsunobu T, et al. Cutoff value of thyroglobulin in needle aspirates for screening neck masses of thyroid carcinoma. Endocrine-Related Cancer. 2024. doi:10.1530/erc-24-0067

BibTeX
@article{Sakamoto2024,
  author = {Sakamoto, Koji and Ozawa, Hiroyuki and Sato, Yoichiro and Nakaishi, Masashi and Sakanushi, Atsuko and Matsunobu, Takeshi and Okubo, Kimihiro and Shinden, Seiichi},
  title = {Cutoff value of thyroglobulin in needle aspirates for screening neck masses of thyroid carcinoma},
  journal = {Endocrine-Related Cancer},
  year = {2024},
  doi = {10.1530/erc-24-0067}
}
Kostenlos starten →